Daclatasvir Nitroso
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Daclatasvir is used along with another medication (sofosbuvir [Solvadi]) to treat a certain type of chronic hepatitis C (an ongoing viral infection that damages the liver). Daclatasvir is in a class of antiviral medications called hepatitis C virus (HCV) NS5A inhibitors.Daclatasvir Nitroso is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Daclatasvir Nitroso CAS NO:NA chemically represented as Methyl ((S)-1-((S)-2-(5-(4'-(2-((S)-1-((methoxycarbonyl)-L-valyl)pyrrolidin-2-yl)-1H-imidazol-5-yl)-[1,1'-biphenyl]-4-yl)-1-nitroso-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate. Synchemia is the leading manufacturing and exporter of Daclatasvir Nitroso . We supply Daclatasvir Nitroso with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143778 |
| CAS No | 69340-07-4 |
| Mol.F. | C4D8N4O2 |
| Mol.Wt. | 152.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143779 |
| CAS No | NA |
| Mol.F. | C13H17N3O2 |
| Mol.Wt. | 247.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143780 |
| CAS No | 61578-30-1 |
| Mol.F. | C4H4D4N2O2 |
| Mol.Wt. | 120.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143781 |
| CAS No | NA |
| Mol.F. | C613CH13D3N2O6 |
| Mol.Wt. | 228.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143782 |
| CAS No | NA |
| Mol.F. | C7H13D3N2O6 |
| Mol.Wt. | 227.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143783 |
| CAS No | NA |
| Mol.F. | C614CH16N2O6 |
| Mol.Wt. | 226.2 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0143784 |
| CAS No | 2124271-47-0 |
| Mol.F. | C22H21D4F2NO4 |
| Mol.Wt. | 409.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143785 |
| CAS No | NA |
| Mol.F. | C22H20D4F2N2O5 |
| Mol.Wt. | 438.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143786 |
| CAS No | 2747915-48-4 |
| Mol.F. | C22H21D4F2NO4 |
| Mol.Wt. | 409.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143787 |
| CAS No | NA |
| Mol.F. | C22H21D4F2NO4 |
| Mol.Wt. | 409.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143788 |
| CAS No | 1219166-00-3 |
| Mol.F. | C22H17D8F2NO4 |
| Mol.Wt. | 413.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143789 |
| CAS No | NA |
| Mol.F. | C28H25N5O4 |
| Mol.Wt. | 495.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143790 |
| CAS No | NA |
| Mol.F. | C17H24N2O4 |
| Mol.Wt. | 320.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143791 |
| CAS No | NA |
| Mol.F. | C13H13N3O6 : 2(Na) |
| Mol.Wt. | 307.3 : 2(23.0) g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143792 |
| CAS No | 19023-40-6 |
| Mol.F. | C12H15F3N2O |
| Mol.Wt. | 260.3 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143793 |
| CAS No | NA |
| Mol.F. | C16H22N2O4 |
| Mol.Wt. | 306.36 g/mole |
| INV STATUS | UNDER SYNTHESIS |